Search alternatives:
wt decrease » we decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
1 decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
16 1 » 16 _ (Expand Search), 1 1 (Expand Search), 6 1 (Expand Search)
wt decrease » we decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
1 decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
16 1 » 16 _ (Expand Search), 1 1 (Expand Search), 6 1 (Expand Search)
-
1
-
2
Spatial training decreases the association between Ndfip1 and Nedd4 and decreases endogenous Beclin 1 ubiquitination in the hippocampus.
Published 2023“…Endogenous Beclin 1 ubiquitination level is decreased in Nedd4 siRNA-transfected rats (t<sub>1,6</sub> = 5.78, <i>p</i> = 0.001). …”
-
3
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
-
4
-
5
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
6
-
7
WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression.
Published 2024“…<p><b>A.</b> Western blotting demonstrates WT1 knockdown in iSLK KSHV BAC-16 cells transfected with WT1 siRNA in comparison to a control siRNA. …”
-
8
-
9
-
10
-
11
Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain.
Published 2020“…<i>fapR</i> mRNA levels were quantified by RT-qPCR using 16S rRNA as reference gene on total RNAs extracted from <i>wt</i> strain (PR01), <i>ΔcshA</i> strain (PR01-ΔcshA), and suppressor strains <i>ΔcshA/accC</i><sup><i>M385V</i></sup> (C51), <i>ΔcshA/accC</i><sup><i>T183I</i></sup> (sup30), <i>ΔcshA/accD</i><sup><i>F253V</i></sup> (sup17), <i>ΔcshA/accD</i><sup><i>A164V</i></sup> (sup16), <i>ΔcshA/birA</i><sup><i>D320F-FsX28</i></sup> (C58), <i>ΔcshA/birA</i><sup><i>R280stop</i></sup> (sup1) and <i>ΔcshA/bioY</i><sup><i>P123R-FsX1</i></sup> (C66), all at exponential growth phase in MH medium at 25°C. n = 5 for <i>ΔcshA</i>, <i>4 for wt</i> and 3 for all others. …”
-
12
-
13
-
14
-
15
GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age.
Published 2021“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
-
16
-
17
GSK343 decreased tumor stemness.
Published 2021“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
-
18
-
19
-
20